Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Funding Key Technologies Research and Development Program of Anhui Province, 2021YFC2100300, Hongbin Wang, National Natural Science Foundation of China, 31871740, Hongbin Wang
The SELECT cardiovascular outcomes trial showed that semaglutide 2.4 mg significantly reduced major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) in patients with established cardiovascular disease and overweight or obesity, even without type 2 diabetes
Your price includes the physician consultation, prescription, medication, and free shipping
The 12 mg dose produced the most dramatic weight loss results but also the highest incidence of adverse events
Soybean flour enriched with a concentrate of blueberry polyphenols was shown to reduce hyperglycemia, weight gain, and serum cholesterol in mice
Wegovy and Zepbound work through the GLP-1 system (and in Zepbounds case, GIP as well)
US$ 22.14
US$ 20.54
US$ 25.92
US$ 25.66
US$ 28.15
US$ 21.88
US$ 22.16
US$ 20.87
US$ 28.18
US$ 20.20
US$ 29.06
